{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:57:11Z","timestamp":1777892231497,"version":"3.51.4"},"reference-count":6,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Royal College of Physicians of Edinburgh"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>The latest UK national human immunodeficiency virus (HIV) testing guidelines, released in September 2008, state that HIV testing should be offered to all patients with indicator conditions and considered in all general medical admissions in high-prevalence areas. We audited testing rates at Blackpool Victoria Hospital, a high-prevalence area, one year before and one year after the publication of the new guidelines. In the year after publication the rate of HIV testing in patients with indicator diseases was as follows: hepatitis B 6%, hepatitis C 28%, tuberculosis 9% and lymphoma 14%. The overall rate of HIV testing in acute medical admissions was 0.5%. Our results demonstrate that traditional methods of guideline dissemination did not lead to implementation. We are now assessing alternative methods such as marking all positive laboratory results for indicator diseases with the phrase \u2018HIV testing should be considered\u2019 and implementing universal opt-out screening in our Clinical Decisions Unit.<\/jats:p>","DOI":"10.4997\/jrcpe.2011.103","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T04:48:55Z","timestamp":1302670135000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence"],"prefix":"10.1177","volume":"41","author":[{"given":"I","family":"Page","sequence":"first","affiliation":[{"name":"ST5 Specialty Registrar in Infectious Diseases, North Manchester General Hospital, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Phillips","sequence":"additional","affiliation":[{"name":"Clinical Lecturer in Medical Education\/Specialist Registrar in Genito-Urinary Medicine, Trinity College, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Flegg","sequence":"additional","affiliation":[{"name":"Infectious Diseases Consultant"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Palmer","sequence":"additional","affiliation":[{"name":"Medical Microbiology Consultant, Blackpool Victoria Hospital, Blackpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"bibr1-JRCPE.2011.103","unstructured":"1British HIV Association. UK national guidelines for HIV testing. London: BHIVA; 2008. Available from: http:\/\/www.bhiva.org\/documents\/Guidelines\/Testing\/GlinesHIVTest08.pdf"},{"key":"bibr2-JRCPE.2011.103","unstructured":"2http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/HIV\/OverallHIVPrevalence"},{"key":"bibr3-JRCPE.2011.103","unstructured":"3Medical Foundation for AIDS &Sexual Health. Recommended standards for NHS HIV services. London: MedFASH; 2003. Available from: http:\/\/www.medfash.org.uk\/publications\/documents\/Recommended_standards_for_NHS_HIV_services.pdf"},{"key":"bibr4-JRCPE.2011.103","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.033258"},{"key":"bibr5-JRCPE.2011.103","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2008.0186"},{"key":"bibr6-JRCPE.2011.103","unstructured":"6 Perry N, Heald L, Cassell J  HIV testing in acute general admissions must be universally offered to reduce undiagnosed HIV infection. HIV Med 2010; 11(Suppl. 1):9. Available from: http:\/\/www.bhiva.org\/documents\/Conferences\/Manchester2010\/Abstracts10Entire.pdf"}],"container-title":["Journal of the Royal College of Physicians of Edinburgh"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/JRCPE.2011.103","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/JRCPE.2011.103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:24:12Z","timestamp":1777616652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4997\/JRCPE.2011.103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.4997\/JRCPE.2011.103"],"URL":"https:\/\/doi.org\/10.4997\/jrcpe.2011.103","relation":{},"ISSN":["1478-2715","2042-8189"],"issn-type":[{"value":"1478-2715","type":"print"},{"value":"2042-8189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}